scispace - formally typeset
S

Satoshi Hoshide

Researcher at Jichi Medical University

Publications -  485
Citations -  16279

Satoshi Hoshide is an academic researcher from Jichi Medical University. The author has contributed to research in topics: Blood pressure & Ambulatory blood pressure. The author has an hindex of 54, co-authored 397 publications receiving 12621 citations. Previous affiliations of Satoshi Hoshide include University of Vigo.

Papers
More filters
Journal ArticleDOI

Morning Surge in Blood Pressure as a Predictor of Silent and Clinical Cerebrovascular Disease in Elderly Hypertensives A Prospective Study

TL;DR: In older hypertensives, a higher morning BP surge is associated with stroke risk independently of ambulatory BP, nocturnal BP falls, and silent infarct, and reduction of the MS could be a new therapeutic target for preventing target organ damage and subsequent cardiovascular events in hypertensive patients.
Journal ArticleDOI

The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019)

TL;DR: The story of the life and times of Toshihiko Umemura and his family in the years leading up to and including his death.
Journal ArticleDOI

Stroke Prognosis and Abnormal Nocturnal Blood Pressure Falls in Older Hypertensives

TL;DR: In older Japanese hypertensive patients, extreme dipping of nocturnal blood pressure may be related to silent and clinical cerebral ischemia through hypoperfusion during sleep or an exaggerated morning rise of blood pressure, whereas reverse dipping may pose a risk for intracranial hemorrhage.
Journal ArticleDOI

Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial

TL;DR: Results from SPYRAL HTN-OFF MED provide biological proof of principle for the blood-pressure-lowering efficacy of renal denervation in the absence of antihypertensive medications.
Journal ArticleDOI

Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial

TL;DR: Renal denervation in the main renal arteries and branches significantly reduced blood pressure compared with sham control with no major safety events.